Skip to main navigation Skip to search Skip to main content

Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy-Induced Peripheral Neuropathy

  • Jonathan Binder
  • Ertu Unver
  • Gayathrimanoj Kopattil
  • Patrick Burke

Press/Media: Public Engagement Activities

Description

Huddersfield, United Kingdom: Paxman Coolers Limited, MedTech company and manufacturer of the Paxman Scalp Cooling System - cryotherapy technology to mitigate the risk of chemotherapy-induced alopecia, today announces they have been selected by the SWOG Cancer Research Network, an independent global cancer research community that designs and conducts publicly funded clinical trials, for the Paxman Limb Cryocompression System (PLCS) to be used in a prospectively designed study looking at prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Period16 Sept 2022

Media coverage

1

Media coverage

  • TitlePaxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy-Induced Peripheral Neuropathy
    Degree of recognitionNational
    Media name/outletPaxman Coolers
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date16/09/22
    URLhttps://paxmanscalpcooling.com/paxman-limb-cryocompression-system-swog-clinica-trial/
    PersonsJonathan Binder, Ertu Unver, Gayathrimanoj Kopattil, Patrick Burke